Literature DB >> 19041150

Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer.

Qingshan Chang1, Yadong Zhang, Kevin J Beezhold, Deepak Bhatia, Hongwen Zhao, Jianguo Chen, Vince Castranova, Xianglin Shi, Fei Chen.   

Abstract

BACKGROUND/AIMS: Aberrant c-Jun N-terminal kinase (JNK) activation has been linked to hepatocellular carcinoma (HCC) in mouse models. It remains unclear whether JNK activation plays an important role in human HCC and, if so, how JNK signaling contributes to the initiation or progression of HCC.
METHODS: The JNK activation, global gene expression, and the status of histone H3 methylations were measured in 31 primary human hepatocellular carcinoma (HCC) samples paired with the adjacent non-cancerous (ANC) tissues.
RESULTS: Enhanced JNK1 activation was noted in 17 out of 31 HCC samples (55%) relative to the corresponding ANC tissues, whereas JNK2 activation was roughly equal between HCC and ANC tissues. This enhancement in JNK1 activation is associated with an increased tumor size and a lack of encapsulation of the tumors. In addition, an association of JNK1 activation with the histone H3 lysines 4 and 9 tri-methylation was observed in the HCC tissues, which leads to an elevated expression of genes regulating cell growth and a decreased expression of the genes for cell differentiation and the p450 family members in HCC.
CONCLUSIONS: These results, thus, suggest that JNK1 plays important roles in the development of human HCC partially through the epigenetic mechanisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19041150      PMCID: PMC4417500          DOI: 10.1016/j.jhep.2008.07.037

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  57 in total

Review 1.  The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3.

Authors:  Ru Cao; Yi Zhang
Journal:  Curr Opin Genet Dev       Date:  2004-04       Impact factor: 5.578

Review 2.  Polycomb silencing mechanisms and the management of genomic programmes.

Authors:  Yuri B Schwartz; Vincenzo Pirrotta
Journal:  Nat Rev Genet       Date:  2007-01       Impact factor: 53.242

3.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.

Authors:  Nathaniel D Heintzman; Rhona K Stuart; Gary Hon; Yutao Fu; Christina W Ching; R David Hawkins; Leah O Barrera; Sara Van Calcar; Chunxu Qu; Keith A Ching; Wei Wang; Zhiping Weng; Roland D Green; Gregory E Crawford; Bing Ren
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

4.  Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer.

Authors:  Yasuko Matsukawa; Shuho Semba; Hirotaka Kato; Akihiko Ito; Kazuyoshi Yanagihara; Hiroshi Yokozaki
Journal:  Cancer Sci       Date:  2006-06       Impact factor: 6.716

Review 5.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

6.  Evidence for an instructive mechanism of de novo methylation in cancer cells.

Authors:  Ilana Keshet; Yeshayahu Schlesinger; Shlomit Farkash; Eyal Rand; Merav Hecht; Eran Segal; Eli Pikarski; Richard A Young; Alain Niveleau; Howard Cedar; Itamar Simon
Journal:  Nat Genet       Date:  2006-02       Impact factor: 38.330

7.  Inhibitor of nuclear factor kappaB kinase deficiency enhances oxidative stress and prolongs c-Jun NH2-terminal kinase activation induced by arsenic.

Authors:  Fei Chen; Vince Castranova; Zhiwei Li; Michael Karin; Xianglin Shi
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

8.  Transcriptional regulation of rat CYP2A3 by nuclear factor 1: identification of a novel NFI-A isoform, and evidence for tissue-selective interaction of NFI with the CYP2A3 promoter in vivo.

Authors:  Guoyu Ling; Charles R Hauer; Richard M Gronostajski; Brian T Pentecost; Xinxin Ding
Journal:  J Biol Chem       Date:  2004-04-28       Impact factor: 5.157

9.  Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma.

Authors:  Pei-Fen Su; Te-Chang Lee; Pei-Ju Lin; Po-Huang Lee; Yung-Ming Jeng; Chien-Hung Chen; Ja-Der Liang; Ling-Ling Chiou; Guan-Tarn Huang; Hsuan-Shu Lee
Journal:  Int J Cancer       Date:  2007-09-15       Impact factor: 7.396

10.  Nucleolin links to arsenic-induced stabilization of GADD45alpha mRNA.

Authors:  Yadong Zhang; Deepak Bhatia; Hongfeng Xia; Vince Castranova; Xianglin Shi; Fei Chen
Journal:  Nucleic Acids Res       Date:  2006-01-18       Impact factor: 16.971

View more
  50 in total

Review 1.  MAPK signaling in inflammation-associated cancer development.

Authors:  Pengyu Huang; Jiahuai Han; Lijian Hui
Journal:  Protein Cell       Date:  2010-02-23       Impact factor: 14.870

Review 2.  Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development.

Authors:  Juan Wang; Guixiang Tai
Journal:  Target Oncol       Date:  2016-12       Impact factor: 4.493

3.  Comparative effects of 4-phenyl-3-butenoic acid and vorinostat on cell growth and signaling.

Authors:  Timothy J Burns; Amna Ali; Diane F Matesic
Journal:  Anticancer Res       Date:  2015-02       Impact factor: 2.480

Review 4.  Molecular classification and novel targets in hepatocellular carcinoma: recent advancements.

Authors:  Yujin Hoshida; Sara Toffanin; Anja Lachenmayer; Augusto Villanueva; Beatriz Minguez; Josep M Llovet
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

5.  JNK and STAT3 signaling pathways converge on Akt-mediated phosphorylation of EZH2 in bronchial epithelial cells induced by arsenic.

Authors:  Bailing Chen; Jia Liu; Qingshan Chang; Kevin Beezhold; Yongju Lu; Fei Chen
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

6.  CD95 promotes tumour growth.

Authors:  Lina Chen; Sun-Mi Park; Alexei V Tumanov; Annika Hau; Kenjiro Sawada; Christine Feig; Jerrold R Turner; Yang-Xin Fu; Iris L Romero; Ernst Lengyel; Marcus E Peter
Journal:  Nature       Date:  2010-05-27       Impact factor: 49.962

7.  NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis.

Authors:  Shin Maeda
Journal:  Gastroenterol Res Pract       Date:  2010-11-28       Impact factor: 2.260

8.  Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.

Authors:  Ryan B Perumpail; Robert J Wong; Aijaz Ahmed; Stephen A Harrison
Journal:  Dig Dis Sci       Date:  2015-08-07       Impact factor: 3.199

Review 9.  Signal integration by JNK and p38 MAPK pathways in cancer development.

Authors:  Erwin F Wagner; Angel R Nebreda
Journal:  Nat Rev Cancer       Date:  2009-08       Impact factor: 60.716

10.  JNK1 activation predicts the prognostic outcome of the human hepatocellular carcinoma.

Authors:  Qingshan Chang; Jianguo Chen; Kevin J Beezhold; Vince Castranova; Xianglin Shi; Fei Chen
Journal:  Mol Cancer       Date:  2009-08-17       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.